成年期血压与晚年脑结构及病理的关联:Insight 46研究
该研究基于1946年英国出生队列的神经科学亚组Insight 46,纳入465名69-71岁无痴呆参与者,分析成年期多个时点血压与晚年脑白质高信号体积、脑体积、淀粉样蛋白状态及认知的关联。发现53岁血压升高及43-53岁血压增幅与晚年白质高信号体积增加相关,43岁舒张压升高及36-43岁增幅与全脑体积减小相关,36-43岁收缩压增幅与海马体积减小相关,但血压与淀粉样蛋白状态或认知评分无关。提示从中年早期开始监测和干预血压可能有助于晚年脑健康。
要点
- 53岁收缩压/舒张压升高及43-53岁增幅与晚年白质高信号体积增加相关。
- 43岁舒张压升高及36-43岁增幅与晚年全脑体积减小相关。
- 36-43岁收缩压增幅与晚年海马体积减小相关。
核心结论
- 从成年早期至中年血压升高及增幅似乎与69-71岁时白质高信号体积增加和脑体积减小相关。
- 未发现血压影响该年龄认知或脑淀粉样蛋白负荷的证据。
- 血压监测和干预可能需在40岁左右开始以最大化晚年脑健康。
研究设计与样本
- Insight 46是1946年英国出生队列的神经科学亚组,初始队列含5362人。
- 血压在36、43、53、60-64和69岁测量,并计算年龄间血压变化。
- 采用T1和FLAIR MRI、florbetapir淀粉样蛋白PET及认知评估。
关键数值与推荐
- 血压与淀粉样蛋白状态或PACC评分无显著关联。
临床怎么用
- 对40岁左右人群应重视血压监测,尤其关注舒张压及血压增幅。
- 中年期血压升高或快速上升可能提示晚年脑结构损伤风险增加。
- 控制血压可能有助于减少晚年白质高信号和脑萎缩,但需进一步干预研究验证。
局限性
- 研究为观察性设计,不能确立因果关系。
- 样本主要为英国1946年出生队列,外推性受限。
- 未发现血压与认知或淀粉样蛋白关联,可能受年龄或随访时间限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Midlife hypertension confers increased risk for cognitive impairment in late life. The sensitive period for risk exposure and extent that risk is mediated through amyloid or vascular-related mechanisms are poorly understood. We aimed to identify if, and when, blood pressure or change in blood pressure during adulthood were associated with late-life brain structure, pathology, and cognition. METHODS: Participants were from Insight 46, a neuroscience substudy of the ongoing longitudinal Medical Research Council National Survey of Health and Development, a birth cohort that initially comprised 5362 individuals born throughout mainland Britain in one week in 1946. Participants aged 69-71 years received T1 and FLAIR volumetric MRI, florbetapir amyloid-PET imaging, and cognitive assessment at University College London (London, UK); all participants were dementia-free. Blood pressure measurements had been collected at ages 36, 43, 53, 60-64, and 69 years. We also calculated blood pressure change variables between ages. Primary outcome measures were white matter hyperintensity volume (WMHV) quantified from multimodal MRI using an automated method, amyloid-β positivity or negativity using a standardised uptake value ratio approach, whole-brain and hippocampal volumes quantified from 3D-T1 MRI, and a composite cognitive score-the Preclinical Alzheimer Cognitive Composite (PACC). We investigated associations between blood pressure and blood pressure changes at and between 36, 43, 53, 60-64, and 69 years of age with WMHV using generalised linear models with a gamma distribution and log link function, amyloid-β status using logistic regression, whole-brain volume and hippocampal volumes using linear regression, and PACC score using linear regression, with adjustment for potential confounders. FINDINGS: Between May 28, 2015, and Jan 10, 2018, 502 individuals were assessed as part of Insight 46. 465 participants (238 [51%] men; mean age 70·7 years [SD 0·7]; 83 [18%] amyloid-β-positive) were included in imaging analyses. Higher systolic blood pressure (SBP) and diastolic blood pressure (DBP) at age 53 years and greater increases in SBP and DBP between 43 and 53 years were positively associated with WMHV at 69-71 years of age (increase in mean WMHV per 10 mm Hg greater SBP 7%, 95% CI 1-14, p=0·024; increase in mean WMHV per 10 mm Hg greater DBP 15%, 4-27, p=0·0057; increase in mean WMHV per one SD change in SBP 15%, 3-29, p=0·012; increase in mean WMHV per 1 SD change in DBP 15%, 3-30, p=0·017). Higher DBP at 43 years of age was associated with smaller whole-brain volume at 69-71 years of age (-6·9 mL per 10 mm Hg greater DBP, -11·9 to -1·9, p=0·0068), as were greater increases in DBP between 36 and 43 years of age (-6·5 mL per 1 SD change, -11·1 to -1·9, p=0·0054). Greater increases in SBP between 36 and 43 years of age were associated with smaller hippocampal volumes at 69-71 years of age (-0·03 mL per 1 SD change, -0·06 to -0·001, p=0·043). Neither absolute blood pressure nor change in blood pressure predicted amyloid-β status or PACC score at 69-71 years of age. INTERPRETATION: High and increasing blood pressure from early adulthood into midlife seems to be associated with increased WMHV and smaller brain volumes at 69-71 years of age. We found no evidence that blood pressure affected cognition or cerebral amyloid-β load at this age. Blood pressure monitoring and interventions might need to start around 40 years of age to maximise late-life brain health. FUNDING: Alzheimer's Research UK, Medical Research Council, Dementias Platform UK, Wellcome Trust, Brain Research UK, Wolfson Foundation, Weston Brain Institute, Avid Radiopharmaceuticals.
引用
- Lane CA, Barnes J, Nicholas JM, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019. PMID: 31444142. doi:10.1016/S1474-4422(19)30228-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。